Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Polycystic ovarian syndrome (PCOS), a hormonal condition which affects how the ovaries work, is thought to affect 20% of women worldwide. Yet despite how common the condition is, and the serious effect it has on women’s health, researchers still aren’t completely sure what causes PCOS – let alone how best to manage and treat the condition.

The Conversation logo

Alongside taking hormonal therapy, most guidance states weight loss is one of the best ways to manage PCOS. Even just a 5% loss of body weight is shown to improve symptoms. Weight loss can also help reduce risk of developing more serious health problems related to excess weight, such as type 2 diabetes, high blood pressure and sleep apnoea.

But hormonal imbalances linked to PCOS can make it difficult for women to lose weight. Historic underfunding for PCOS-centred research also means there’s a serious lack of reliable, evidence-based guidance on the best ways to lose weight – and what PCOS symptoms may improve as a result.

This leads many women to turn to the internet, where diet advice is abundant. But this information is often profit-driven and potentially grounded in misinformation. Not only does this questionable diet advice provide false hope for people with PCOS, it may also be putting them at risk of harm – including disordered eating.

 

Read the full story on The Conversation website co-authored by Sharon Dixon, Researcher, Jadine Scragg, Researcher and Cervantée Wild, Research Fellow, all of the Nuffield Department for Primary Care Health Sciences, University of Oxford.

Oxford is a subscribing member of The Conversation. Find out how you can write for The Conversation.

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience

Researchers uncover genetic changes in the bacteria causing severe Kent meningococcal disease outbreak

The research, led by scientists at the Dunn School, the Biology Department, and the UK Health Security Agency, analysed the genome of bacteria that caused the outbreak, which affected 21 people in Kent during March this year.